We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

40 hedge funds and large institutions have $65.3M invested in Genocea Biosciences, Inc. in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more call options, than puts

Call options by funds: $388K | Put options by funds: $140K

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

13% less funds holding

Funds holding: 46 → 40 (-6)

18% less capital invested

Capital invested by funds: $79.4M → $65.3M (-$14.1M)

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

Holders
40
Holders Change
-6
Holders Change %
-13.04%
% of All Funds
0.7%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
2
Increased
12
Reduced
8
Closed
8
Calls
$388K
Puts
$140K
Net Calls
+$248K
Net Calls Change
-$395K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$301K
2
CC
Commodore Capital
New York
+$296K
3
Millennium Management
Millennium Management
New York
+$180K
4
Group One Trading
Group One Trading
Illinois
+$82.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$48.5K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$208K
2
Two Sigma Investments
Two Sigma Investments
New York
-$190K
3
DC
Diametric Capital
Massachusetts
-$164K
4
PCM
Prelude Capital Management
New York
-$102K
5
UOC
UBS O'Connor
Illinois
-$45K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$30K -$1.64K -835 -5%
PCA
27
Personal Capital Advisors
California
$29K – – –
WA
28
WealthTrust Axiom
Pennsylvania
$28K – – –
JMPWA
29
JP Morgan Private Wealth Advisors
California
$24K – – –
CAAS
30
Capital Asset Advisory Services
Michigan
$23K – – –
Wells Fargo
31
Wells Fargo
California
$18K +$267 +136 +1%
VRM
32
Vectors Research Management
New York
$12K +$1.97K +1,000 +20%
TRCT
33
Tower Research Capital (TRC)
New York
$11K -$5.25K -2,672 -31%
ACM
34
ACT Capital Management
Pennsylvania
$10K – – –
First Manhattan
35
First Manhattan
New York
$4K – – –
AWA
36
Artemis Wealth Advisors
New York
$2.18K – – –
Osaic Holdings
37
Osaic Holdings
Arizona
$2K – – –
Federated Hermes
38
Federated Hermes
Pennsylvania
$2K +$2.04K +1,037 New
CG
39
Cutler Group
California
$1K – – –
Northwestern Mutual Wealth Management
40
Northwestern Mutual Wealth Management
Wisconsin
$1K +$1.23K +625 New
DC
41
Diametric Capital
Massachusetts
– -$164K -69,977 Closed
PCM
42
Prelude Capital Management
New York
– -$102K -43,643 Closed
UOC
43
UBS O'Connor
Illinois
– -$45K -19,170 Closed
VF
44
Virtu Financial
New York
– -$37K -15,625 Closed
ECM
45
ExodusPoint Capital Management
New York
– -$26K -11,131 Closed
PCM
46
Pinz Capital Management
New York
– -$17K -7,200 Closed
UBS Group
47
UBS Group
Switzerland
– -$9K -3,834 Closed
Citigroup
48
Citigroup
New York
– -$1K -250 Closed
1
2

GNCA Hedge Fund Activity: Q3 2021 in Review

40 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q3 2021, worth a combined $65.3M — down 18% from $79.4M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of GNCA and 2 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 12 added.

The largest buyer was Point72 Asset Management, adding an estimated $301K. The largest seller was Two Sigma Advisers, cutting an estimated $208K.

  • 40 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q3 2021, down from 46 in Q2 2021.
  • Funds reported $65.3M of Genocea Biosciences, Inc. stock for Q3 2021, down 18% quarter-over-quarter.
  • 2 funds opened new Genocea Biosciences, Inc. positions in Q3 2021 and 8 closed out, a net change of -6 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q3 2021 was Point72 Asset Management, an estimated $301K added.
  • The largest Genocea Biosciences, Inc. seller in Q3 2021 was Two Sigma Advisers, an estimated $208K sold.

Based on aggregated 13F filings for Q3 2021.